BLGO
BIOLARGO, INC.
+0.00 (+1.33%)0.09USD10.0K成交股數30.0M市值–本益比(近四季)7.3股價營收比-55.1%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.2M-55% | 1.1M-66% | 616K-86% | 1.1M-78% | 2.8M-42% | 3.3M-25% | 4.4M+63% | 5.0M+247% | 4.8M | 4.4M | 2.7M | 1.4M |
| 營業成本 | 573K | 657K | 491K | 731K | 1.4M | 1.8M | 2.6M | 2.9M | 2.5M | 2.3M | 1.2M | 627K |
| 毛利 | 675K-52% | 458K-69% | 125K-93% | 372K-83% | 1.4M-37% | 1.5M-29% | 1.7M+20% | 2.1M+161% | 2.2M | 2.1M | 1.4M | 819K |
| 毛利率 | 54.1% | 41.1% | 20.3% | 33.7% | 51.2% | 45.5% | 39.6% | 42.6% | 47.2% | 47.8% | 53.7% | 56.6% |
| 研發費用 | 1.1M | 907K | 652K | 615K | 535K | 791K | 690K | 623K | 784K | 436K | 694K | 587K |
| 銷售管理費用 | 3.3M | 2.8M | 3.5M | 3.1M | 2.7M | 2.5M | 2.1M | 2.4M | 2.2M | 2.3M | 2.3M | 1.8M |
| 營業利益 | −3.7M+107% | −3.2M+72% | −4.0M+278% | −7.2M+707% | −1.8M+136% | −1.9M+85% | −1.1M-31% | −890K-43% | −763K | −1.0M | −1.5M | −1.6M |
| 營業利益率 | -298.7% | -287.4% | -651.1% | -651.0% | -64.9% | -57.0% | -24.4% | -17.8% | -16.0% | -23.0% | -57.5% | -107.8% |
| 稅後淨利 | −4.0M+113% | −3.4M+77% | −4.1M+291% | −7.2M+829% | −1.9M+143% | −1.9M+88% | −1.1M-30% | −780K-52% | −775K | −1.0M | −1.5M | −1.6M |
| 淨利率 | -320.5% | -305.4% | -672.4% | -656.8% | -67.8% | -58.8% | -24.4% | -15.6% | -16.3% | -23.3% | -56.4% | -112.4% |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 2.2M | 4.1M | 3.9M | 4.5M | 3.5M | 2.6M | 3.9M | 4.8M | 4.3M | 3.5M | 3.0M | 3.6M |
| 應收帳款 | 724K | 730K | 615K | 761K | 1.7M | 4.2M | 3.2M | 2.1M | 2.5M | 2.6M | 1.5M | 1.0M |
| 存貨 | 303K | 292K | 310K | 409K | 444K | 369K | 238K | 176K | 251K | 153K | 122K | 127K |
| 總資產 | 6.7M | 8.6M | 8.3M | 9.1M | 12.5M | 10.5M | 10.3M | 10.1M | 9.8M | 8.2M | 6.5M | 6.7M |
| 有息負債 | – | – | 2.1M | – | – | – | 180K | 184K | 284K | 289K | 293K | 299K |
| 總負債 | 9.4M | 8.8M | 6.8M | 5.9M | 6.4M | 5.4M | 4.3M | 4.2M | 4.7M | 4.0M | 2.7M | 2.6M |
| 股東權益 | −1.9M | 1.8M | 4.0M | 6.6M | 8.8M | 7.6M | 8.6M | 6.0M | 8.1M | 6.8M | 7.1M | 7.4M |
| 負債比 | 140.9% | 102.2% | 81.6% | 64.8% | 51.5% | 51.6% | 42.0% | 41.4% | 47.6% | 48.8% | 41.7% | 38.3% |
| 淨現金(現金 − 有息負債) | – | – | 1.8M | – | – | – | 3.7M | 4.6M | 4.1M | 3.3M | 2.7M | 3.3M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.9M+59% | – | – | – | −1.8M | – | – | 481K | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 8.5M
| Odor No More | 5.9M | 69.2% | -62.1% |
|---|---|---|---|
| Biolargo Engineering Science Technologies LLC | 2.5M | 29.8% | -20.4% |
| Biolargo Canada | 86K | 1.0% | +19.4% |
產品／服務2025 年度 · 7.8M
| 產品 | 5.8M | 74.3% | -65.6% |
|---|---|---|---|
| 服務 | 2.0M | 25.7% | +96.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 7.8M | -56.3% | −15.2M | -195.6% | – | – |
| FY2024 | 17.8M | +45.4% | −4.3M | -24.5% | – | – |
| FY2023 | 12.2M | +107.9% | −4.6M | -38.0% | – | – |
| FY2022 | 5.9M | +132.5% | −5.1M | -87.2% | – | – |
| FY2021 | 2.5M | +4.1% | −6.9M | -272.4% | -0.03 | – |
| FY2020 | 2.4M | +30.7% | −9.7M | -398.8% | -0.05 | – |
| FY2019 | 1.9M | +36.4% | −11.4M | -614.7% | -0.08 | – |
| FY2018 | 1.4M | – | −10.7M | -784.2% | -0.09 | – |